Your browser doesn't support javascript.
Can the hyperthermia-mediated heat shock factor/heat shock protein 70 pathway dampen the cytokine storm during SARS-CoV-2 infection?
Rébé, Cédric; Ghiringhelli, François; Garrido, Carmen.
  • Rébé C; Platform of Transfer in Cancer Biology, Centre Georges François Leclerc, INSERM LNC UMR1231, University of Bourgogne Franche-Comté, Dijon, France.
  • Ghiringhelli F; Platform of Transfer in Cancer Biology, Centre Georges François Leclerc, INSERM LNC UMR1231, University of Bourgogne Franche-Comté, Dijon, France.
  • Garrido C; INSERM LNC UMR1231, University of Bourgogne Franche-Comté, Centre Georges François Leclerc, Dijon, France.
Br J Pharmacol ; 179(21): 4910-4916, 2022 11.
Article in English | MEDLINE | ID: covidwho-972694
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major global public health problem. Infection by this virus involves many pathophysiological processes, such as a "cytokine storm," that is, very aggressive inflammatory response that offers new perspectives for the management and treatment of patients. Here, we analyse relevant mechanism involved in the hyperthermia-mediated heat shock factors (HSFs)/heat shock proteins (HSP)70 pathway which may provide a possible treatment tool. LINKED ARTICLES This article is part of a themed issue on The Pharmacology of COVID-19. To view the other articles in this section visit http//onlinelibrary.wiley.com/doi/10.1111/bph.v177.21/issuetoc.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hyperthermia, Induced Limits: Humans Language: English Journal: Br J Pharmacol Year: 2022 Document Type: Article Affiliation country: Bph.15343

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hyperthermia, Induced Limits: Humans Language: English Journal: Br J Pharmacol Year: 2022 Document Type: Article Affiliation country: Bph.15343